CMPS - Compass a new outperform at RBC on optimism for psychedelic-based therapies
2024-07-23 15:20:39 ET
More on COMPASS Pathways ADS
- Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
- Psychedelics Closer To Commercialization; Compass Far And Away The Leader
- FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (updated)
- Psychedelic stocks fall as FDA panel rejects MDMA therapy
- COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript